Exicure Inc – Ordinary Shares

Exicure Inc is a clinical-stage biotechnology company which develops a new class of immunomodulatory and gene silencing drugs against validated targets. It uses spherical nucleic acid technology platform to build a pipeline of products for a range of diseases with unmet medical needs. The company addresses diseases, such as oncology, immunology, and dermatology.